CAVERS GREG enters HELUS PHARMA INC. with 125.94K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/2/2026ACC: 0000912282-26-001333
Officer· Chief Financial Officer
Since Sep 2026
125.94K
Baseline shares
100% direct
125.94K
Direct ownership
1 position
66.67K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned125.94K
Total
125.94K direct125.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 125.94K | Direct |
| Total | 125.94K | 125.94K direct |
Derivative Holdings1
Restricted Stock Units
DirectUnderlying security
Common Shares
Underlying shares
66.67K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
66.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares | — | — | 66.67K | N/A | |
| Total | 66.67K | 0.00 | ||||